CN101525627A - Dual-gene co-expression plasmid, engineering bacteria transformed therefrom and construction method thereof - Google Patents

Dual-gene co-expression plasmid, engineering bacteria transformed therefrom and construction method thereof Download PDF

Info

Publication number
CN101525627A
CN101525627A CN200810034359A CN200810034359A CN101525627A CN 101525627 A CN101525627 A CN 101525627A CN 200810034359 A CN200810034359 A CN 200810034359A CN 200810034359 A CN200810034359 A CN 200810034359A CN 101525627 A CN101525627 A CN 101525627A
Authority
CN
China
Prior art keywords
plasmid
seq
ply
gene
neu5ac
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200810034359A
Other languages
Chinese (zh)
Inventor
王立军
朱丽
陈代杰
戈梅
罗敏玉
魏维
潘广文
夏兴
王天骄
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Laiyi Biomedical Research And Development Center LLC
Zhejiang Medicine Co Ltd Xinchang Pharmaceutical Factory
Original Assignee
Shanghai Laiyi Biomedical Research And Development Center LLC
Zhejiang Medicine Co Ltd Xinchang Pharmaceutical Factory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Laiyi Biomedical Research And Development Center LLC, Zhejiang Medicine Co Ltd Xinchang Pharmaceutical Factory filed Critical Shanghai Laiyi Biomedical Research And Development Center LLC
Priority to CN200810034359A priority Critical patent/CN101525627A/en
Publication of CN101525627A publication Critical patent/CN101525627A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention provides a dual-gene co-expression plasmid, engineering bacteria transformed from the dual-gene co-expression plasmid and a construction method thereof. The dual-gene co-expression plasmid contains a N-acetylneuraminate lyase gene, a N-acyl-D-glucosamine 2-isomerase gene and a proper expression vector, the engineering bacteria can be obtained after the plasmid is transformed into Escherichia coli, thalli obtained after the fermentation culture of the engineering bacteria are crushed and then are centrifugated, then a centrifugated supernatant is added into a GlcNAc reaction liquid, and Neu5Ac can be generated through the catalysis. The plasmid and the corresponding engineering bacteria can be used for preparing the Neu5Ac. At the same time, the preparation of the Neu5Ac by the method can simplify a method of two-bacteria secondary fermentation usually needed when a two-step enzyme method prepares the Neu5Ac into single-bacteria primary fermentation, which can realize the aim of preparing two biocatalysts, simplify the processes of fermentation technology and production technology of enzyme-producing bacteria, and improve the production efficiency and the yield of the Neu5Ac.

Description

The engineering bacteria of a kind of double gene coexpression plasmid, its conversion and construction process thereof
Technical field
The invention belongs to the genetically engineered field, specifically, relate to the engineering bacteria and the construction process thereof of a kind of double gene coexpression plasmid, its conversion.
Background technology
N-n acetylneuraminic acid n (Neu5Ac) is the precursor of neuraminidase inhibitor, and this inhibitor is used for the treatment of viral influenza clinically, has important use and be worth in field of medicaments.
Have multiplely though obtain the method for Neu5Ac, to have technology simple because biotransformation method prepares Neu5Ac, and purifying is convenient, pollute advantages such as few, therefore mainly now adopts this method preparation.The process that biotransformation method generates Neu5Ac is divided into two kinds of a step enzyme method and two step enzyme methods.Wherein a step enzyme method promptly utilizes N-n acetylneuraminic acid n lyase catalyzing N-acetylmannosamine (ManNAc) and pyruvic acid (pyruvate) directly to generate Neu5Ac.This method step is simple, and transformation efficiency and productive rate are all more satisfactory, but the price limit of the costliness of ManNAc the application of this method.Two step enzyme methods are promptly used N-acetyl-D-glucosamine 2-isomerase earlier N-acetyl-D-glucosamine (GlcNAc) to be transformed and are generated ManNAc, generate Neu5Ac by the catalysis of N-n acetylneuraminic acid n lyase again, and this process sees Fig. 1 for details.
1985, people such as Ohta announced coding e. coli k12 (Escherichia coli K12) N-n acetylneuraminic acid n lyase genes (nal) sequence, and had successfully cloned this gene in 1986 years.Subsequently, people such as Maru successfully cloned N-acetyl-D-glucosamine 2-isomerase gene (age) from the pig kidney in 1996.The existing at present independent expression plasmid that utilizes N-n acetylneuraminic acid n lyase genes nal and N-acetyl-D-glucosamine 2-isomerase gene age to make up respectively still owing to the production process relative complex of two step enzyme methods, therefore is necessary further to be improved.
Summary of the invention
Primary and foremost purpose of the present invention is improved with regard to being the technology of two step enzyme methods being produced N-n acetylneuraminic acid n (Neu5Ac), thereby the double gene coexpression plasmid of a kind of N-n acetylneuraminic acid n lyase and N-acetyl-D-glucosamine 2-isomerase is provided.
Second purpose of the present invention is to provide a kind of construction process of described double gene coexpression plasmid.
The 3rd purpose of the present invention is to provide a kind of genetic engineering bacterium that utilizes described double gene coexpression plasmid to transform.
The 4th purpose of the present invention is to provide a kind of construction process of described engineering bacteria.
The 5th purpose of the present invention is to provide a kind of method of utilizing described engineering bacteria to produce Neu5Ac.
Double gene coexpression plasmid of the present invention contains N-n acetylneuraminic acid n lyase genes nal and N-acetyl-D-glucosamine 2-isomerase gene age simultaneously.
The present invention utilizes plasmid pLY-3, pET-29a-nal and pQE30-nal amplification to obtain N-n acetylneuraminic acid n lyase genes nal Expression element respectively, under the effect of ligase enzyme, be connected to plasmid pLY-AGE, the pET-29a-age and the pQE30-age that contain N-acetyl-D-glucosamine 2-isomerase gene age Expression element then, make up and obtain double gene coexpression plasmid.
With described double gene coexpression plasmid transformed into escherichia coli, acquisition can be expressed the genetic engineering bacterium of N-n acetylneuraminic acid n lyase and N-acetyl-D-glucosamine 2-isomerase simultaneously.
Described engineering bacteria is fermented under suitable condition, and it is centrifugal to collect bacterial cell disruption, and the supernatant crude enzyme liquid of acquisition can be converted into Neu5Ac with substrate GlcNAc.
The genetic engineering bacterium that utilizes double gene coexpression plasmid of the present invention to make up, can express N-n acetylneuraminic acid n lyase and N-acetyl-D-glucosamine 2-isomerase simultaneously, thereby can be implemented in the primary first-order equation process, GlcNAc catalysis is generated Neu5Ac, simplify production process greatly, improved the productive rate of production efficiency and Neu5Ac.
Description of drawings
Fig. 1 is that two step enzyme methods prepare the Neu5Ac schematic flow sheet.
Fig. 2 is a double gene coexpression plasmid pLY-NA structural representation.
Fig. 3 is a double gene coexpression plasmid pLY-9 structural representation.
Fig. 4 is a double gene coexpression plasmid pLY-10 structural representation.
Fig. 5 is a construction recombination plasmid pLY-NA schema, and wherein, 5A is the preparation flow figure of pLY-NAL subclone, and 5B is the structure schema of recombinant plasmid pLY-NA.
Fig. 6 is a construction recombination plasmid pLY-9 schema, and wherein, 6A is the preparation flow figure of pLY-NAL-1 subclone, and 6B is the structure schema of recombinant plasmid pLY-9.
Fig. 7 is a construction recombination plasmid pLY-10 schema, and wherein, 7A is the preparation flow figure of pLY-NAL-2 subclone, and 7B is the structure schema of recombinant plasmid pLY-10.
Fig. 8 is the electrophoresis result of the Expression element pcr amplification of N-n acetylneuraminic acid n lyase genes nal.
Fig. 9 is that the enzyme of pLY-NA plasmid is cut rear electrophoresis checking picture, and wherein, electrophoretic band 1 is cut the result for the SphI enzyme of pLY-NA plasmid, and electrophoretic band 2 is contrast (pLY-AGE).
Figure 10 is (pLY-NA) the broken supernatant crude enzyme liquid of a bacterium electrophoresis result of E.coli BL21 (DE3), wherein electrophoretic band 1 is the molecular weight of albumen standard, electrophoretic band 2 is thick enzyme supernatant, and wherein 42Kda's is N-acetyl-D-glucosamine 2-isomerase, and 33Kda's is N-n acetylneuraminic acid n lyase.
Figure 11 is a Neu5Ac standard substance linear analysis typical curve.
Figure 12 is standard substance Neu5Ac mass spectrometric detection figure.
Figure 13 is standard substance GlcNAc mass spectrometric detection figure.
Figure 14 is the thick enzyme 12h conversion fluid mass spectrometric detection figure that (pLY-NA) is prepared by genetic engineering bacterium E.coli BL21 (DE3).
Figure 15 detects figure by the thick enzyme 12h conversion fluid HPLC that genetic engineering bacterium E.coli BL21 (DE3) (pLY-NA) prepares, and wherein 15A is standard substance HPLC result, and 15B is the detected result of thick enzyme 12h conversion fluid.
Figure 16 detects figure by the thick enzyme 12h conversion fluid HPLC that genetic engineering bacterium E.coli BL21 (DE3) (pLY-10) prepares, and wherein 16A is standard substance HPLC result, and 16B is the detected result of thick enzyme 12h conversion fluid.
Figure 17 is that wherein 17A is standard substance HPLC result by the thick enzyme 12h conversion fluid HPLC detection figure of genetic engineering bacterium E.coli DH α (pLY-9) preparation, and 17B is the detected result of thick enzyme 12h conversion fluid.
Embodiment
Below in conjunction with specific embodiment, the invention will be further described.Should be understood that following examples only are used to the present invention is described but not are used to limit scope of the present invention.
The experimental technique of unreceipted actual conditions in the following example, usually according to normal condition, the condition described in " molecular cloning: laboratory manual " (New York:Cold Spring Harbor Laboratory Press, 1989) is carried out.
Used following bacterial strain and plasmid in the embodiments of the invention:
Intestinal bacteria (E.coli BL21 (DE3)): NOVAGEN company.
Intestinal bacteria (E.coli DH5 α): TIANGEN company.
Plasmid pMD18-T Simple Vector:TAKARA company has amicillin resistance (amp R) and beta-galactosidase enzymes (LacZ) operator gene;
PET30a: expression plasmid has the T7 promotor, kalamycin resistance gene, NOVAGEN company.
PET29a: expression plasmid has the T7 promotor, kalamycin resistance gene, NOVAGEN company.
PQE30: expression plasmid has the T5 promotor, ampicillin resistance gene, Qiagen company.
Plasmid pLY-AGE, pET-29a-age and pQE30-age: with reference to Lee, Y-C. (Production ofN-acetyl-d-neuraminic acid by recombinant whole cells expressing Anabaena sp.CH1N-acetyl-d-glucosamine 2-epimerase and Escherichia coli N-acetyl-D-neuraminic acid lyase such as the document that waits, J.Biotechnol.2007, the method of describing 129:453-460) makes up, respectively by different expression plasmid pET 30a, pET29a and pQE30 make up and form pLY-AGE, pET-29a-age has kalamycin resistance (kan R) and the age gene expression element, pQE30-age has amicillin resistance (amp R) and the age gene expression element.
Plasmid pLY-3, pET-29a-nal and pQE30-nal: with reference to Mahmoudia M., the document of Noble D. (Aneffcient process for N-acetylneura-minic acid using N-acetylneuraminic acid[J], Enz.Micro.Tech., 1997,20:399~400) method of describing in makes up, formed by different expression plasmid pET 30a, pET29a and pQE30 structure respectively, pLY-3 and pET-29a-nal have kalamycin resistance (kan R) and the nal gene expression element, pQE30-nal has amicillin resistance (amp R) and the nal gene expression element.
PLY-NAL: be connected the subclone that makes up by the nal gene expression element that obtains through pcr amplification from pLY-3 with pMD18-T Simple Vector.
PLY-NAL-1: be connected the subclone that makes up by the nal gene expression element that obtains through pcr amplification from pQE30-nal with pMD18-T SimpleVector.
PLY-NAL-2: be connected the subclone that makes up by the nal gene expression element that obtains through pcr amplification from pET-29a-nal with pMD18-T SimpleVector.
PLY-NA: subclone pLY-NAL enzyme cut obtains the nal gene expression element, be connected to the pLY-AGE plasmid then, the co-expression plasmid of nal that is built into and age gene, plasmid map as shown in Figure 2, the host bacterium of this expression plasmid is e.coli BL21 (DE3).
PLY-9: subclone pLY-NAL-1 enzyme cut obtains the nal gene expression element, be connected to the pQE30-age plasmid then, the co-expression plasmid of nal that is built into and age gene, plasmid map as shown in Figure 3, the host bacterium of this expression plasmid is E.coli DH α.
PLY-10; Subclone pLY-NAL-2 enzyme cut obtains the nal gene expression element, be connected to the pET-29a-age plasmid then, the co-expression plasmid of nal that is built into and age gene, plasmid map as shown in Figure 4, the host bacterium of this expression plasmid is E.coli BL21 (DE3).
The building process of three kinds of double gene coexpression plasmids (pLY-NA, pLY-9 and pLY-10) is basic identical, change it over to corresponding expressive host colon bacillus after, can both express and have and transform to generate the Neu5Ac activity.Its building process is as follows:
Utilize the plasmid of expressing nal and age gene respectively that has made up, example pLY-3 and pLY-AGE, it contains nal and age gene expression element respectively, utilizing the method for PCR that the nal gene expression element is increased from the former obtains, after making up subclone, again the nal gene expression element is connected to the latter by suitable restriction endonuclease sites, finally obtains two enzyme co-expression plasmids, concrete structure flow process is seen Fig. 5-7.
Embodiment 1, double gene coexpression plasmid pLY-NA structure
The construction process of double gene coexpression plasmid pLY-NA as shown in Figure 3, detailed process is as follows:
1.1, the preparation of pLY-NAL subclone
1.1.1, design of primers
According to the following PCR primer of the sequences Design of plasmid pLY-3:
P5: GCATGCATCCGGATATAGTTCCTCC
P6:GAGCACCGCCGCCGCAAG
In primer P5, introduced the restriction enzyme site (shown in the underscore) of restriction enzyme SphI; Simultaneously, because contain the restriction enzyme site of a SphI among the plasmid pLY-3, and position suitable, the applicant has utilized this restriction enzyme site, thereby, but still make the two ends of final amplified fragments all contain the restriction enzyme site of SphI less than the restriction enzyme site of in P6, introducing restriction enzyme SphI.
1.1.2, pcr amplification
With plasmid pLY-3 is template, is that primer carries out pcr amplification with P5 and P6, specific as follows:
Reaction system (50 μ l): 10 * Ex Taq Buffer, 5 μ l; P5 (20 μ M), 1 μ l; P6 (20 μ M), 1 μ l; PLY-3,1 μ l; DNTP mixture (each 2.5Mm), 4 μ l; MgCl 2(25 mM), 4 μ l; TaKaRa Ex Taq, 0.5 μ l; DdH 2O, 33.5 μ l.
Reaction conditions: 94 ℃, 4min; 94 ℃, 1min, 55 ℃, 1min, 72 ℃, 2min circulates 29 times; 72 ℃, 10min.
The amplified production that pcr amplification is obtained carries out agarose electrophoresis, and the result according to this result, has located band as shown in Figure 8 about 1.4kb, illustrates that amplification has obtained the Expression element of N-n acetylneuraminic acid n lyase genes nal.
The DNA running gel that amplification is obtained cuts out the gel that contains required dna fragmentation under long wavelength (302nm) ultraviolet lamp.With reference to operational manual, to use the gel of V-GENE company to reclaim the test kit recovery, and check order reclaiming fragment, its sequence is shown in SEQ ID NO:2.
Sequencing result shows that the N-n acetylneuraminic acid n lyase genes nal Expression element that is obtained comprises N-n acetylneuraminic acid n lyase genes nal, T7 promotor, T7 terminator and SD sequence.
1.1.3, the acquisition of pLY-NAL subclone
With reference to service manual, N-n acetylneuraminic acid n lyase genes nal Expression element and pMD18-T Simple Vector under the catalysis of T4 dna ligase (TaKaRa company's T 4 dna ligase test kits), are connected 30min in 16 ℃.The connection product that uses the heat shock method to obtain transforms DH5 α competent cell (TIANGEN company), then on the LB flat board that contains IPTG, X-gal and 100 μ g/ml penbritins, cultivated 16 hours in 37 ℃, the single bacterium colony of picking male white at random from the flat board, extract plasmid and carry out the restriction enzyme digestion and electrophoresis checking, determine to contain on the plasmid DNA pcr amplified fragment of 1.4kb, with the recombinant plasmid called after subclone pLY-NAL that obtains.
1.2, plasmid pLY-NA makes up
1.2.1, plasmid pLY-AGE handles
After the plasmid pLY-AGE that will contain N-acetyl-D-glucosamine 2-isomerase gene age cuts with the SphI enzyme, replenish distilled water to 100 μ l, add isopyknic phenol again: chloroform (1: 1) extract extracting 1~2 time, with 20 μ l chloroform extractings 1 time, in aqueous phase solution, add the 3mol/L sodium acetate of its 1/10 volume and the isopropanol precipitating enzyme of 0.6 times of volume then respectively and cut the back dna fragmentation; Collecting precipitation is used 1ml 70% washing with alcohol precipitation 1 time, blots residual liquid, makes and precipitates drying, obtains the pLY-AGE endonuclease bamhi of purifying, and the TE damping fluid with 25 μ l dissolves the pLY-AGE endonuclease bamhi precipitation of the purifying of acquisition again again.
With reference to service manual, use alkaline phosphatase CIAP (available from TaKaRa company), to carry out dephosphorylation with TE damping fluid dissolved plasmid pLY-AGE endonuclease bamhi handles, use the dephosphorylized plasmid pLY-AGE of the method purifying endonuclease bamhi of above-mentioned purifying pLY-AGE endonuclease bamhi again, and dissolve with the TE damping fluid.
1.2.2, the processing of pLY-NAL subclone
With pLY-NAL subclone SphI single endonuclease digestion, enzyme is cut product and is tapped rubber behind agarose gel electrophoresis and reclaim the N-n acetylneuraminic acid n lyase genes nal Expression element nucleotide sequence that size is about 1.4kb.
1.2.3, plasmid pLY-NA preparation
With the dephosphorylized pLY-AGE endonuclease bamhi of above 1.2.1 acquisition and the N-n acetylneuraminic acid n lyase genes nal Expression element sequence of 1.2.2 acquisition, 1: 7 in molar ratio ratio connects 30min with T4 dna ligase (using TaKaRa company's T 4 dna ligase test kits) in 16 ℃, the connection product that obtains heat shock method Transformed E .coli DH5 α competent cell, then on the LB solid medium that contains 50 μ g/ml kantlex 37 ℃ cultivated 16 hours, choose resistance transformant list bacterium colony, be transferred to 3ml and contain the LB liquid nutrient medium of 50 μ g/ml kantlex, in 37 ℃ of overnight incubation.
Extracting plasmid from cultivate the bacterium liquid that obtains, carry out enzyme and cut checking, the result as shown in Figure 9, according to this figure result, enzyme is cut has size to be about the segment of 1.4kb in the product, determine that N-n acetylneuraminic acid n lyase genes nal Expression element sequence has been connected in the pLY-AGE plasmid, the recombinant plasmid of acquisition is double gene coexpression plasmid, called after pLY-NA.
Through sequence verification, the sequence of double gene coexpression plasmid pLY-NA is shown in SEQ ID NO:1, and wherein, 179-1342 is N-acetyl-D-glucosamine 2-isomerase gene age, and 1854-2747 is N-n acetylneuraminic acid n lyase genes nal; The structure of plasmid pLY-NA as shown in Figure 2.
Embodiment 2, the pLY-NA transformed into escherichia coli
The double gene coexpression plasmid pLY-NA that embodiment 1 is obtained is transformed into and uses CaCl 2Intestinal bacteria E.coliBL21 (DE3) competent cell of method preparation, then on the LB solid medium that contains 50 μ g/ml kantlex 37 ℃ cultivated 16 hours, choose resistance transformant list bacterium colony, obtain the genetic engineering bacterium of double gene coexpression, called after E.coli BL21 (DE3) (pLY-NA).
Embodiment 3, double gene coexpression plasmid pLY-10 structure and conversion
The method of pressing embodiment 1 makes up double gene coexpression plasmid pLY-10, and the method for pressing embodiment 2 is with its Transformed E .coli BL21 (DE3) competent cell, obtain two enzyme co-expression gene engineering bacteria E.coli BL21 (DE3) (pLY-10), wherein, the primer of preparation pLY-NAL-2 subclone is:
P13: GCATGC?ATCCGGATATAGTTCCTCCT
P14:AGGTTGAGGCCGTTGAGCAC
Wherein, in primer P13, introduced the restriction enzyme site (shown in the underscore) of restriction enzyme SphI; Simultaneously, because contain the restriction enzyme site of a SphI among the plasmid pET-29a-nal, and position suitable, the applicant has utilized this restriction enzyme site, thereby, but still make the two ends of final amplified fragments all contain the restriction enzyme site of SphI less than the restriction enzyme site of in P6 and P14, introducing restriction enzyme SphI.
Embodiment 4, double gene coexpression plasmid pLY-9 structure and conversion
The method of pressing embodiment 1 makes up double gene coexpression plasmid pLY-9, and the method for pressing embodiment 2 is with its Transformed E .coliDH5 α competent cell, obtain two enzyme co-expression gene engineering bacteria E.coli DH α (pLY-9), wherein, the primer of preparation pLY-NAL-1 subclone is:
P11:AAATAGGCGTATCACGAGGC
P12: CTCGAG?GTGGTATATCCAGTGATTTT
Wherein, in primer P12, introduced the restriction enzyme site XhoI (shown in the underscore) of restriction enzyme; Simultaneously, because pQE30-nal contains one XhoI restriction enzyme site in the plasmid, and position suitable, the applicant has utilized this restriction enzyme site, thereby not in P11, do not introduce the restriction enzyme site of restriction enzyme XhoI, but still make the XhoI restriction enzyme site that the two ends of final amplified fragments are all contained.
Embodiment 5, E.coli BL21 (DE3) (pLY-NA), E.coli BL21 (DE3) (pLY-10) and the fermentation of E.coli DH α (pLY-9)
With the genetic engineering bacterium E.coli BL21 (DE3) of the double gene coexpression for preparing in the foregoing description (pLY-NA), E.coli BL21 (DE3) (pLY-10) and E.coli DH α (pLY-9), be inoculated into respectively in the 3ml LB liquid nutrient medium, in 37 ℃, cultivated 16 hours.
Get 16 hours bacterium liquid of above-mentioned cultivation, inoculum size with 1.0%, (E.coliDH α (pLY-9) cultivates in the selective pressure of penbritin to be transferred to 50ml LB liquid nutrient medium respectively, E.coli BL21 (DE3) (pLY-10) (pLY-NA) cultivates under the selective pressure of kantlex with E.coli BL21 (DE3)) in, 37 ℃ are cultured to mid-log phase (A 550=0.5~1), adds lactose (final concentration is 1mM) then, induce.
With the bacterium liquid of inducing culture after 8 hours, in 4 ℃, the centrifugal 5min of 8000rpm, collect centrifugation, obtain bacterial sediment, wash thalline three times with phosphate buffered saline buffer, each 10ml, use the resuspended thalline of Tris-HCl lysis buffer 10ml of 10mM pH7.4 again, and the ultrasonication cell, in 4 ℃, 15000rpm with cytoclasis solution centrifugal 15min after, gather in the crops centrifugal supernatant, promptly obtain respectively corresponding three kinds of engineering bacteria E.coli BL21 (DE3) (pLY-NA), E.coli BL21 (DE3) (pLY-10) and the crude enzyme liquid I of E.coli DH α (pLY-9), crude enzyme liquid II and crude enzyme liquid III.
Get the supernatant crude enzyme liquid respectively and carry out the SDS-PAGE detection, and scan, analyze the content of two enzymes with gel imaging system.Detected result shows, described two kinds of enzymes, and N-n acetylneuraminic acid n lyase and N-acetyl-D-glucosamine 2-isomerase all has expression in crude enzyme liquid I, crude enzyme liquid II and crude enzyme liquid III; Wherein, among the crude enzyme liquid I, N-n acetylneuraminic acid n lyase accounts for 30% of total protein, and N-acetyl-D-glucosamine 2-isomerase accounts for 15% of total protein, among the crude enzyme liquid II, N-n acetylneuraminic acid n lyase accounts for 29% of total protein, N-acetyl-D-glucosamine 2-isomerase accounts for 17% of total protein, and among the crude enzyme liquid III, N-n acetylneuraminic acid n lyase accounts for 27% of total protein, N-acetyl-D-glucosamine 2-isomerase accounts for 18% of total protein, and the electrophoresis result of crude enzyme liquid I as shown in figure 10.
Embodiment 6, crude enzyme liquid transforms N-acetyl-D-glucosamine (GlcNAc)
Get above-mentioned each 300 μ l of three kinds of crude enzyme liquids that obtain after centrifugal, be mixed with three 1ml water react systems (25mMTris-HCl (pH 7.4), 50mM GlcNAc, 200mM Sodium.alpha.-ketopropionate, 180 μ M ATP, 200 μ M MgCl respectively 2), under 30 ℃ of conditions, 120rpm transforms 12h.
In 80 ℃, thermal treatment 5min is with stopped reaction with the solution after transforming.
Embodiment 7, product detects
7.1, mass spectrometric detection
The 12h conversion reaction liquid of Neu5Ac standard substance, reaction substrate GlcNAc and crude enzyme liquid I is done mass spectrometric detection, and detected result shown in Figure 12~14, according to this result, defines Neu5Ac and generates respectively.
7.2, HPLC detects
Take by weighing Neu5Ac 5mg, to 10ml, be prepared as Neu5Ac scalar solution with the pure water constant volume available from SIGMA company; Then in contrast, respectively the 12h conversion reaction liquid of crude enzyme liquid I, II and III is detected through HPLC that (use Agilent 1100 type liquid chromatographs to detect, testing conditions is: detect wavelength 220nm with Neu5Ac scalar solution; Flow velocity 1ml/min; Sample size 5 μ l), the result is shown in Figure 15-17.
Simultaneously, also the Neu5Ac standard substance are carried out linear analysis, its concrete operations are as follows: precision takes by weighing standard substance, and compound concentration (μ g/ml) is 27,56,112,225,450,900.Sample introduction 5 μ l carry out linear regression analysis with peak area to concentration successively, obtain regression equation Y=1.4133X+1.1879, R 2=0.998, the result as shown in figure 11.This result shows that the linear relationship of peak area and concentration relationship in 27~900 μ g/ml scopes of Neu5Ac under these conditions is good, therefore, can utilize peak area to be directly proportional with concentration in this concentration range, thereby measure the content of Neu5Ac in the solution to be measured.Result according to Figure 15-17 also can get as calculated, and the final growing amount of crude enzyme liquid I, crude enzyme liquid II and crude enzyme liquid III product Neu5Ac is respectively 1.3mg/ml, 1.5mg/ml and 1.7mg/ml; The quality transformation efficiency is 11.8%, 13.6% and 15.4% (method of calculation of quality transformation efficiency is as follows).
Figure A20081003435900121
The above results shows, E.coli BL21 (DE3) (pLY-NA), E.coli BL21 (DE3) (pLY-10) and E.coliDH α (pLY-9) can be used for preparation and contain the crude enzyme liquid of described pair of enzyme (N-n acetylneuraminic acid n lyase and N-acetyl-D-glucosamine 2-isomerase), and proved that above-mentioned crude enzyme liquid has the ability that conversion of substrate GlcNAc generates Neu5Ac.
In sum, plasmid pLY-NA provided by the invention, but transformed into escherichia coli obtain engineering bacteria; The engineering bacteria that obtains is after fermentation culture, contain two kinds of required purpose enzymes (N-n acetylneuraminic acid n lyase and N-acetyl-D-glucosamine 2-isomerase) in the thalline that obtains, described two kinds of purpose enzymes are present in the supernatant of the centrifugal back of bacterial cell disruption, and this crude enzyme liquid of centrifugal supernatant of acquisition has the ability that conversion of substrate GlcNAc generates Neu5Ac.
Therefore, plasmid pLY-NA provided by the invention, pLY-9 and pLY-10, and the engineering bacteria of transformed into escherichia coli acquisition all can be used for preparing Neu5Ac.Use method provided by the invention to prepare Neu5Ac, in the time of common two step enzyme methods can being prepared Neu5Ac the method for two required bacterium fermenting twice be reduced to single bacterium (E.coliBL21 (DE3) (pLY-NA), E.coliBL21 (DE3) (pLY-10) or E.coli DH α (pLY-9)) one time fermentation, just can realize preparing the purpose of two kinds of biological catalysts, simplify the zymotechnique of zymogenic bacteria.Simultaneously, described double gene coexpression plasmid contains the gene of N-n acetylneuraminic acid n lyase and N-acetyl-D-glucosamine 2-isomerase, after transforming engineering bacteria, can express described two kinds of enzymes, thereby can be by reaction process once, GlcNAc catalysis is generated Neu5Ac, simplified production process greatly, improved the productive rate of production efficiency and Neu5Ac.
Sequence table
<110〉company limited of the next beneficial bio-pharmaceutical in Shanghai research and development centre
<120>P5071052
<130〉engineering bacteria of a kind of double gene coexpression plasmid, its conversion and construction process thereof
<160>4
<170>PatentIn?version?3.1
<210>1
<211>7822
<212>DNA
<213〉plasmid pLY-NA
<400>1
atccggatat?agttcctcct?ttcagcaaaa?aacccctcaa?gacccgttta?gaggccccaa 60
ggggttatgc?tagttattgc?tcagcggtgg?cagcagccaa?ctcagcttcc?tttcgggctt 120
tgttagcagc?cggatctcag?tggtggtggt?ggtggtgctc?gagtgcggcc?gcaagcttac 180
tcaaggcctc?gaattgttgc?caacacagat?acaaagcacg?gggtacatga?aaacatccct 240
tccatttacc?gcctttgaga?tttaacagca?cttccccacg?gcgatttaag?tagccaaacc 300
actcaccata?ttctgggtca?gcaaaatgct?gccaagaata?atcgtgcatt?ttttgatacc 360
attcccaaca?gacttcacga?cctgtcaaac?gataacccat?cgccaaagcc?accaaagatt 420
ctaaatgcac?ccaccacaat?ttttgatccc?attccaattg?ttgtggggga?tgacctgctg 480
catccataaa?gtaatacaag?ccgccatact?ctttatccca?ggcgaaattg?aggatattta 540
acaccacatc?aactgcttgg?ttaatagtct?tgctgtcgtt?tttccgtcgg?gcgatgtcca 600
taataaacca?catcgcctca?ataccgtgac?cagggttaat?cagccgccct?tcaaaacaat 660
caatgtggga?accatcgggg?gcaacatttt?catacatcaa?tcctcgttct?ttgtcgagaa 720
agtcactcat?aacttcctga?acggttgcac?tcaagacatt?ttctagagtc?tcctggggaa 780
gcaaccattc?catttctaag?gtcaggttag?ctaaaatcat?tggcacagct?aaggctttca 840
tggggcgtgt?gccgggatag?gttttggtat?atttgccttt?gggattatct?ttgcgacgca 900
aaacattgtt?atatgcttgc?atagccacat?cttttgccca?ctcttcacca?gaggcgagag 960
catattggct?aaaggccatc?gctgcaaaac?aatcagaaaa?aatattgtaa?ggctgtacta 1020
atggttcacc?tccacgggtg?agggcaaaat?accagtttcc?ctctgcgtct?ctgccatgtt 1080
gggcaagaaa?tttagcaccg?ttactagcaa?ttttgagcca?gttttcccgt?ttttctagct 1140
ggttacacag?catggaaaaa?gtccagactt?ggcggttttg?cagccaaata?aatttatctg 1200
tgtcatacac?cttaccctgg?cgatcaagac?aggtaaaata?accgccttcc?gtatccaggg 1260
agtggttttc?ccaaaacggg?agtacgtcgt?tgaggagggc?atttttgtaa?agttgcgcca 1320
gtgcttgtaa?gtttttcccc?atatgtatat?ctccttctta?aagttaaaca?aaattatttc 1380
tagaggggaa?ttgttatccg?ctcacaattc?ccctatagtg?agtcgtatta?atttcgcggg 1440
atcgagatcg?atctcgatcc?tctacgccgg?acgcatcgtg?gccggcatca?ccggcgccac 1500
aggtgcggtt?gctggcgcct?atatcgccga?catcaccgat?ggggaagatc?gggctcgcca 1560
cttcgggctc?atgagcgctt?gtttcggcgt?gggtatggtg?gcaggccccg?tggccggggg 1620
actgttgggc?gccatctcct?tgcatgcatc?cggatatagt?tcctcctttc?agcaaaaaac 1680
ccctcaagac?ccgtttagag?gccccaaggg?gttatgctag?ttattgctca?gcggtggcag 1740
cagccaactc?agcttccttt?cgggctttgt?tagcagccgg?atctcagtgg?tggtggtggt 1800
ggtgctcgag?tgcggccgca?agcttgtcga?cggagctcga?attcggatcc?aactcacccg 1860
cgctcttgca?tcaactgctg?ggccagcgcc?ttcagttctg?gcagatattt?ttcatctacc 1920
ggtccaaacg?gtttgcggca?cagcggcaca?gaaacgacat?ccatataatg?gaggacagtt 1980
ttcaggccgc?ggaatacgcc?cgttttgatc?agtaaatcaa?tgactttatt?gcattcagtt 2040
tgcagtttct?gcgcggtctg?gatatcgcct?tctttcagcg?ccttaacgat?cccctgatag 2100
cgccagccca?tgatgttgta?ggtactgccg?ataccaccat?cagcgcccgc?cagcagacca 2160
gaggcgaaga?tttcgtcgta?accgttatag?agcacaagat?caggatgttc?acgacggatc 2220
tgctccatct?gatagagatc?gccagaggtc?tgtttcagcg?cacctacgcc?aggcaatgta 2280
acaagtgtgt?tgatctgatc?cagggtcagt?tttaccccac?tcagggctgg?aatgttgtac 2340
accaccatcg?gcaaaccatc?cgccgaatca?ataattgccc?gatagtgatc?gcagtgttct 2400
tcaaagctga?aaggatagta?gaacggcgtg?acggcggaga?cggcatcgaa?gccataacgt 2460
ttagccgatg?ccgcaagttg?ttggctttcg?gcggtgctga?cgcaaccgac?gtgggcgatg 2520
agtttaatct?tacctttcgc?ctcttcggcg?acgatttcca?gtacctgttc?acgctcggaa 2580
aggctttgta?caaaggcctc?gccggtcgaa?ccacccacgt?ataaaccgtc?gatgccctgc 2640
tgaatattga?actgaaccag?gcgacgcaga?ctcgctttat?ccagtgcttg?ttgttggtca 2700
aaaggagtca?ggagtgcagc?cattacgcca?cgtaaattcg?ttgccatatg?tatatctcct 2760
tcttaaagtt?aaacaaaatt?atttctagag?gggaattgtt?atccgctcac?aattccccta 2820
tagtgagtcg?tattaatttc?gcgggatcga?gatcgatctc?gatcctctac?gccggacgca 2880
tcgtggccgg?catcaccggc?gccacaggtg?cggttgctgg?cgcctatatc?gccgacatca 2940
ccgatgggga?agatcgggct?cgccacttcg?ggctcatgag?cgcttgtttc?ggcgtgggta 3000
tggtggcagg?ccccgtggcc?gggggactgt?tgggcgccat?ctccttgcat?gcaccattcc 3060
ttgcggcggc?ggtgctcaac?ggcctcaacc?tactactggg?ctgcttccta?atgcaggagt 3120
cgcataaggg?agagcgtcga?gatcccggac?accatcgaat?ggcgcaaaac?ctttcgcggt 3180
atggcatgat?agcgcccgga?agagagtcaa?ttcagggtgg?tgaatgtgaa?accagtaacg 3240
ttatacgatg?tcgcagagta?tgccggtgtc?tcttatcaga?ccgtttcccg?cgtggtgaac 3300
caggccagcc?acgtttctgc?gaaaacgcgg?gaaaaagtgg?aagcggcgat?ggcggagctg 3360
aattacattc?ccaaccgcgt?ggcacaacaa?ctggcgggca?aacagtcgtt?gctgattggc 3420
gttgccacct?ccagtctggc?cctgcacgcg?ccgtcgcaaa?ttgtcgcggc?gattaaatct 3480
cgcgccgatc?aactgggtgc?cagcgtggtg?gtgtcgatgg?tagaacgaag?cggcgtcgaa 3540
gcctgtaaag?cggcggtgca?caatcttctc?gcgcaacgcg?tcagtgggct?gatcattaac 3600
tatccgctgg?atgaccagga?tgccattgct?gtggaagctg?cctgcactaa?tgttccggcg 3660
ttatttcttg?atgtctctga?ccagacaccc?atcaacagta?ttattttctc?ccatgaagac 3720
ggtacgcgac?tgggcgtgga?gcatctggtc?gcattgggtc?accagcaaat?cgcgctgtta 3780
gcgggcccat?taagttctgt?ctcggcgcgt?ctgcgtctgg?ctggctggca?taaatatctc 3840
actcgcaatc?aaattcagcc?gatagcggaa?cgggaaggcg?actggagtgc?catgtccggt 3900
tttcaacaaa?ccatgcaaat?gctgaatgag?ggcatcgttc?ccactgcgat?gctggttgcc 3960
aacgatcaga?tggcgctggg?cgcaatgcgc?gccattaccg?agtccgggct?gcgcgttggt 4020
gcggacatct?cggtagtggg?atacgacgat?accgaagaca?gctcatgtta?tatcccgccg 4080
ttaaccacca?tcaaacagga?ttttcgcctg?ctggggcaaa?ccagcgtgga?ccgcttgctg 4140
caactctctc?agggccaggc?ggtgaagggc?aatcagctgt?tgcccgtctc?actggtgaaa 4200
agaaaaacca?ccctggcgcc?caatacgcaa?accgcctctc?cccgcgcgtt?ggccgattca 4260
ttaatgcagc?tggcacgaca?ggtttcccga?ctggaaagcg?ggcagtgagc?gcaacgcaat 4320
taatgtaagt?tagctcactc?attaggcacc?gggatctcga?ccgatgccct?tgagagcctt 4380
caacccagtc?agctccttcc?ggtgggcgcg?gggcatgact?atcgtcgccg?cacttatgac 4440
tgtcttcttt?atcatgcaac?tcgtaggaca?ggtgccggca?gcgctctggg?tcattttcgg 4500
cgaggaccgc?tttcgctgga?gcgcgacgat?gatcggcctg?tcgcttgcgg?tattcggaat 4560
cttgcacgcc?ctcgctcaag?ccttcgtcac?tggtcccgcc?accaaacgtt?tcggcgagaa 4620
gcaggccatt?atcgccggca?tggcggcccc?acgggtgcgc?atgatcgtgc?tcctgtcgtt 4680
gaggacccgg?ctaggctggc?ggggttgcct?tactggttag?cagaatgaat?caccgatacg 4740
cgagcgaacg?tgaagcgact?gctgctgcaa?aacgtctgcg?acctgagcaa?caacatgaat 4800
ggtcttcggt?ttccgtgttt?cgtaaagtct?ggaaacgcgg?aagtcagcgc?cctgcaccat 4860
tatgttccgg?atctgcatcg?caggatgctg?ctggctaccc?tgtggaacac?ctacatctgt 4920
attaacgaag?cgctggcatt?gaccctgagt?gatttttctc?tggtcccgcc?gcatccatac 4980
cgccagttgt?ttaccctcac?aacgttccag?taaccgggca?tgttcatcat?cagtaacccg 5040
tatcgtgagc?atcctctctc?gtttcatcgg?tatcattacc?cccatgaaca?gaaatccccc 5100
ttacacggag?gcatcagtga?ccaaacagga?aaaaaccgcc?cttaacatgg?cccgctttat 5160
cagaagccag?acattaacgc?ttctggagaa?actcaacgag?ctggacgcgg?atgaacaggc 5220
agacatctgt?gaatcgcttc?acgaccacgc?tgatgagctt?taccgcagct?gcctcgcgcg 5280
tttcggtgat?gacggtgaaa?acctctgaca?catgcagctc?ccggagacgg?tcacagcttg 5340
tctgtaagcg?gatgccggga?gcagacaagc?ccgtcagggc?gcgtcagcgg?gtgttggcgg 5400
gtgtcggggc?gcagccatga?cccagtcacg?tagcgatagc?ggagtgtata?ctggcttaac 5460
tatgcggcat?cagagcagat?tgtactgaga?gtgcaccata?tatgcggtgt?gaaataccgc 5520
acagatgcgt?aaggagaaaa?taccgcatca?ggcgctcttc?cgcttcctcg?ctcactgact 5580
cgctgcgctc?ggtcgttcgg?ctgcggcgag?cggtatcagc?tcactcaaag?gcggtaatac 5640
ggttatccac?agaatcaggg?gataacgcag?gaaagaacat?gtgagcaaaa?ggccagcaaa 5700
aggccaggaa?ccgtaaaaag?gccgcgttgc?tggcgttttt?ccataggctc?cgcccccctg 5760
acgagcatca?caaaaatcga?cgctcaagtc?agaggtggcg?aaacccgaca?ggactataaa 5820
gataccaggc?gtttccccct?ggaagctccc?tcgtgcgctc?tcctgttccg?accctgccgc 5880
ttaccggata?cctgtccgcc?tttctccctt?cgggaagcgt?ggcgctttct?catagctcac 5940
gctgtaggta?tctcagttcg?gtgtaggtcg?ttcgctccaa?gctgggctgt?gtgcacgaac 6000
cccccgttca?gcccgaccgc?tgcgccttat?ccggtaacta?tcgtcttgag?tccaacccgg 6060
taagacacga?cttatcgcca?ctggcagcag?ccactggtaa?caggattagc?agagcgaggt 6120
atgtaggcgg?tgctacagag?ttcttgaagt?ggtggcctaa?ctacggctac?actagaagga 6180
cagtatttgg?tatctgcgct?ctgctgaagc?cagttacctt?cggaaaaaga?gttggtagct 6240
cttgatccgg?caaacaaacc?accgctggta?gcggtggttt?ttttgtttgc?aagcagcaga 6300
ttacgcgcag?aaaaaaagga?tctcaagaag?atcctttgat?cttttctacg?gggtctgacg 6360
ctcagtggaa?cgaaaactca?cgttaaggga?ttttggtcat?gaacaataaa?actgtctgct 6420
tacataaaca?gtaatacaag?gggtgttatg?agccatattc?aacgggaaac?gtcttgctct 6480
aggccgcgat?taaattccaa?catggatgct?gatttatatg?ggtataaatg?ggctcgcgat 6540
aatgtcgggc?aatcaggtgc?gacaatctat?cgattgtatg?ggaagcccga?tgcgccagag 6600
ttgtttctga?aacatggcaa?aggtagcgtt?gccaatgatg?ttacagatga?gatggtcaga 6660
ctaaactggc?tgacggaatt?tatgcctctt?ccgaccatca?agcattttat?ccgtactcct 6720
gatgatgcat?ggttactcac?cactgcgatc?cccgggaaaa?cagcattcca?ggtattagaa 6780
gaatatcctg?attcaggtga?aaatattgtt?gatgcgctgg?cagtgttcct?gcgccggttg 6840
cattcgattc?ctgtttgtaa?ttgtcctttt?aacagcgatc?gcgtatttcg?tctcgctcag 6900
gcgcaatcac?gaatgaataa?cggtttggtt?gatgcgagtg?attttgatga?cgagcgtaat 6960
ggctggcctg?ttgaacaagt?ctggaaagaa?atgcataaac?ttttgccatt?ctcaccggat 7020
tcagtcgtca?ctcatggtga?tttctcactt?gataacctta?tttttgacga?ggggaaatta 7080
ataggttgta?ttgatgttgg?acgagtcgga?atcgcagacc?gataccagga?tcttgccatc 7140
ctatggaact?gcctcggtga?gttttctcct?tcattacaga?aacggctttt?tcaaaaatat 7200
ggtattgata?atcctgatat?gaataaattg?cagtttcatt?tgatgctcga?tgagtttttc 7260
taagaattaa?ttcatgagcg?gatacatatt?tgaatgtatt?tagaaaaata?aacaaatagg 7320
ggttccgcgc?acatttcccc?gaaaagtgcc?acctgaaatt?gtaaacgtta?atattttgtt 7380
aaaattcgcg?ttaaattttt?gttaaatcag?ctcatttttt?aaccaatagg?ccgaaatcgg 7440
caaaatccct?tataaatcaa?aagaatagac?cgagataggg?ttgagtgttg?ttccagtttg 7500
gaacaagagt?ccactattaa?agaacgtgga?ctccaacgtc?aaagggcgaa?aaaccgtcta 7560
tcagggcgat?ggcccactac?gtgaaccatc?accctaatca?agttttttgg?ggtcgaggtg 7620
ccgtaaagca?ctaaatcgga?accctaaagg?gagcccccga?tttagagctt?gacggggaaa 7680
gccggcgaac?gtggcgagaa?aggaagggaa?gaaagcgaaa?ggagcgggcg?ctagggcgct 7740
ggcaagtgta?gcggtcacgc?tgcgcgtaac?caccacaccc?gccgcgctta?atgcgccgct 7800
acagggcgcg?tcccattcgc?ca 7822
<210>2
<211>1436
<212>DNA
<213〉N-n acetylneuraminic acid n lyase genes nal Expression element
<400>2
gcatgcatcc?ggatatagtt?cctcctttca?gcaaaaaacc?cctcaagacc?cgtttagagg 60
ccccaagggg?ttatgctagt?tattgctcag?cggtggcagc?agccaactca?gcttcctttc 120
gggctttgtt?agcagccgga?tctcagtggt?ggtggtggtg?gtgctcgagt?gcggccgcaa 180
gcttgtcgac?ggagctcgaa?ttcggatcca?actcacccgc?gctcttgcat?caactgctgg 240
gccagcgcct?tcagttctgg?cagatatttt?tcatctaccg?gtccaaacgg?tttgcggcac 300
agcggcacag?aaacgacatc?catataatgg?aggacagttt?tcaggccgcg?gaatacgccc 360
gttttgatca?gtaaatcaat?gactttattg?cattcagttt?gcagtttctg?cgcggtctgg 420
atatcgcctt?ctttcagcgc?cttaacgatc?ccctgatagc?gccagcccat?gatgttgtag 480
gtactgccga?taccaccatc?agcgcccgcc?agcagaccag?aggcgaagat?ttcgtcgtaa 540
ccgttataga?gcacaagatc?aggatgttca?cgacggatct?gctccatctg?atagagatcg 600
ccagaggtct?gtttcagcgc?acctacgcca?ggcaatgtaa?caagtgtgtt?gatctgatcc 660
agggtcagtt?ttaccccact?cagggctgga?atgttgtaca?ccaccatcgg?caaaccatcc 720
gccgaatcaa?taattgcccg?atagtgatcg?cagtgttctt?caaagctgaa?aggatagtag 780
aacggcgtga?cggcggagac?ggcatcgaag?ccataacgtt?tagccgatgc?cgcaagttgt 840
tggctttcgg?cggtgctgac?gcaaccgacg?tgggcgatga?gtttaatctt?acctttcgcc 900
tcttcggcga?cgatttccag?tacctgttca?cgctcggaaa?ggctttgtac?aaaggcctcg 960
ccggtcgaac?cacccacgta?taaaccgtcg?atgccctgct?gaatattgaa?ctgaaccagg 1020
cgacgcagac?tcgctttatc?cagtgcttgt?tgttggtcaa?aaggagtcag?gagtgcagcc 1080
attacgccac?gtaaattcgt?tgccatatgt?atatctcctt?cttaaagtta?aacaaaatta 1140
tttctagagg?ggaattgtta?tccgctcaca?attcccctat?agtgagtcgt?attaatttcg 1200
cgggatcgag?atcgatctcg?atcctctacg?ccggacgcat?cgtggccggc?atcaccggcg 1260
ccacaggtgc?ggttgctggc?gcctatatcg?ccgacatcac?cgatggggaa?gatcgggctc 1320
gccacttcgg?gctcatgagc?gcttgtttcg?gcgtgggtat?ggtggcaggc?cccgtggccg 1380
ggggactgtt?gggcgccatc?tccttgcatg?caccattcct?tgcggcggcg?gtgctc 1436
<210>3
<211>5824
<212>DNA
<213〉plasmid pLY-9
<400>3
ctcgagaaat?cataaaaaat?ttatttgctt?tgtgagcgga?taacaattat?aatagattca 60
attgtgagcg?gataacaatt?tcacacagaa?ttcattaaag?aggagaaatt?aactatgaga 120
ggatcgcatc?accatcacca?tcacggatcc?atggcaacga?atttacgtgg?cgtaatggct 180
gcactcctga?ctccttttga?ccaacaacaa?gcactggata?aagcgagtct?gcgtcgcctg 240
gttcagttca?atattcagca?gggcatcgac?ggtttatacg?tgggtggttc?gaccggcgag 300
gcctttgtac?aaagcctttc?cgagcgtgaa?caggtactgg?aaatcgtcgc?cgaagaggcg 360
aaaggtaaga?ttaaactcat?cgcccacgtc?ggttgcgtca?gcaccgccga?aagccaacaa 420
cttgcggcat?cggctaaacg?ttatggcttc?gatgccgtct?ccgccgtcac?gccgttctac 480
tatcctttca?gctttgaaga?acactgcgat?cactatcggg?caattattga?ttcggcggat 540
ggtttgccga?tggtggtgta?caacattcca?gccctgagtg?gggtaaaact?gaccctggat 600
cagatcaaca?cacttgttac?attgcctggc?gtaggtgcgc?tgaaacagac?ctctggcgat 660
ctctatcaga?tggagcagat?ccgtcgtgaa?catcctgatc?ttgtgctcta?taacggttac 720
gacgaaatct?tcgcctctgg?tctgctggcg?ggcgctgatg?gtggtatcgg?cagtacctac 780
aacatcatgg?gctggcgcta?tcaggggatc?gttaaggcgc?tgaaagaagg?cgatatccag 840
accgcgcaga?aactgcaaac?tgaatgcaat?aaagtcattg?atttactgat?caaaacgggc 900
gtattccgcg?gcctgaaaac?tgtcctccat?tatatggatg?tcgtttctgt?gccgctgtgc 960
cgcaaaccgt?ttggaccggt?agatgaaaaa?tatctgccag?aactgaaggc?gctggcccag 1020
cagttgatgc?aagagcgcgg?gtgaaagctt?aattagctga?gcttggactc?ctgttgatag 1080
atccagtaat?gacctcagaa?ctccatctgg?atttgttcag?aacgctcggt?tgccgccggg 1140
cgttttttat?tggtgagaat?ccaagctagc?ttggcgagat?tttcaggagc?taaggaagct 1200
aaaatggaga?aaaaaatcac?tggatatacc?acctcgagaa?atcataaaaa?atttatttgc 1260
tttgtgagcg?gataacaatt?ataatagatt?caattgtgag?cggataacaa?tttcacacag 1320
aattcattaa?agaggagaaa?ttaactatga?gaggatcgca?tcaccatcac?catcacggat 1380
ccatggggaa?aaacttacaa?gcactggcgc?aactttacaa?aaatgccctc?ctcaacgacg 1440
tactcccgtt?ttgggaaaac?cactccctgg?atacggaagg?cggttatttt?acctgtcttg 1500
atcgccaggg?taaggtgtat?gacacagata?aatttatttg?gctgcaaaac?cgccaagtct 1560
ggactttttc?catgctgtgt?aaccagctag?aaaaacggga?aaactggctc?aaaattgcta 1620
gtaacggtgc?taaatttctt?gcccaacatg?gcagagacgc?agagggaaac?tggtattttg 1680
ccctcacccg?tggaggtgaa?ccattagtac?agccttacaa?tattttttct?gattgttttg 1740
cagcgatggc?ctttagccaa?tatgctctcg?cctctggtga?agagtgggca?aaagatgtgg 1800
ctatgcaagc?atataacaat?gttttgcgtc?gcaaagataa?tcccaaaggc?aaatatacca 1860
aaacctatcc?cggcacacgc?cccatgaaag?ccttagctgt?gccaatgatt?ttagctaacc 1920
tgaccttaga?aatggaatgg?ttgcttcccc?aggagactct?agaaaatgtc?ttgagtgcaa 1980
ccgttcagga?agttatgagt?gactttctcg?acaaagaacg?aggattgatg?tatgaaaatg 2040
ttgcccccga?tggttcccac?attgattgtt?ttgaagggcg?gctgattaac?cctggtcacg 2100
gtattgaggc?gatgtggttt?attatggaca?tcgcccgacg?gaaaaacgac?agcaagacta 2160
ttaaccaagc?agttgatgtg?gtgttaaata?tcctcaattt?cgcctgggat?aaagagtatg 2220
gcggcttgta?ttactttatg?gatgcagcag?gtcatccccc?acaacaattg?gaatgggatc 2280
aaaaattgtg?gtgggtgcat?ttagaatctt?tggtggcttt?ggcgatgggt?tatcgtttga 2340
caggtcgtga?agtctgttgg?gaatggtatc?aaaaaatgca?cgattattct?tggcagcatt 2400
ttgctgaccc?agaatatggt?gagtggtttg?gctacttaaa?tcgccgtggg?gaagtgctgt 2460
taaatctcaa?aggcggtaaa?tggaagggat?gttttcatgt?accccgtgct?ttgtatctgt 2520
gttggcaaca?attcgaggcc?ttgagttaaa?agcttaatta?gctgagcttg?gactcctgtt 2580
gatagatcca?gtaatgacct?cagaactcca?tctggatttg?ttcagaacgc?tcggttgccg 2640
ccgggcgttt?tttattggtg?agaatccaag?ctagcttggc?gagattttca?ggagctaagg 2700
aagctaaaat?ggagaaaaaa?atcactggat?ataccaccgt?tgatatatcc?caatggcatc 2760
gtaaagaaca?ttttgaggca?tttcagtcag?ttgctcaatg?tacctataac?cagaccgttc 2820
agctggatat?tacggccttt?ttaaagaccg?taaagaaaaa?taagcacaag?ttttatccgg 2880
cctttattca?cattcttgcc?cgcctgatga?atgctcatcc?ggaatttcgt?atggcaatga 2940
aagacggtga?gctggtgata?tgggatagtg?ttcacccttg?ttacaccgtt?ttccatgagc 3000
aaactgaaac?gttttcatcg?ctctggagtg?aataccacga?cgatttccgg?cagtttctac 3060
acatatattc?gcaagatgtg?gcgtgttacg?gtgaaaacct?ggcctatttc?cctaaagggt 3120
ttattgagaa?tatgtttttc?gtctcagcca?atccctgggt?gagtttcacc?agttttgatt 3180
taaacgtggc?caatatggac?aacttcttcg?cccccgtttt?caccatgggc?aaatattata 3240
cgcaaggcga?caaggtgctg?atgccgctgg?cgattcaggt?tcatcatgcc?gtttgtgatg 3300
gcttccatgt?cggcagaatg?cttaatgaat?tacaacagta?ctgcgatgag?tggcagggcg 3360
gggcgtaatt?tttttaaggc?agttattggt?gcccttaaac?gcctggggta?atgactctct 3420
agcttgaggc?atcaaataaa?acgaaaggct?cagtcgaaag?actgggcctt?tcgttttatc 3480
tgttgtttgt?cggtgaacgc?tctcctgagt?aggacaaatc?cgccctctag?agctgcctcg 3540
cgcgtttcgg?tgatgacggt?gaaaacctct?gacacatgca?gctcccggag?acggtcacag 3600
cttgtctgta?agcggatgcc?gggagcagac?aagcccgtca?gggcgcgtca?gcgggtgttg 3660
gcgggtgtcg?gggcgcagcc?atgacccagt?cacgtagcga?tagcggagtg?tatactggct 3720
taactatgcg?gcatcagagc?agattgtact?gagagtgcac?catatgcggt?gtgaaatacc 3780
gcacagatgc?gtaaggagaa?aataccgcat?caggcgctct?tccgcttcct?cgctcactga 3840
ctcgctgcgc?tcggtcgttc?ggctgcggcg?agcggtatca?gctcactcaa?aggcggtaat 3900
acggttatcc?acagaatcag?gggataacgc?aggaaagaac?atgtgagcaa?aaggccagca 3960
aaaggccagg?aaccgtaaaa?aggccgcgtt?gctggcgttt?ttccataggc?tccgcccccc 4020
tgacgagcat?cacaaaaatc?gacgctcaag?tcagaggtgg?cgaaacccga?caggactata 4080
aagataccag?gcgtttcccc?ctggaagctc?cctcgtgcgc?tctcctgttc?cgaccctgcc 4140
gcttaccgga?tacctgtccg?cctttctccc?ttcgggaagc?gtggcgcttt?ctcatagctc 4200
acgctgtagg?tatctcagtt?cggtgtaggt?cgttcgctcc?aagctgggct?gtgtgcacga 4260
accccccgtt?cagcccgacc?gctgcgcctt?atccggtaac?tatcgtcttg?agtccaaccc 4320
ggtaagacac?gacttatcgc?cactggcagc?agccactggt?aacaggatta?gcagagcgag 4380
gtatgtaggc?ggtgctacag?agttcttgaa?gtggtggcct?aactacggct?acactagaag 4440
gacagtattt?ggtatctgcg?ctctgctgaa?gccagttacc?ttcggaaaaa?gagttggtag 4500
ctcttgatcc?ggcaaacaaa?ccaccgctgg?tagcggtggt?ttttttgttt?gcaagcagca 4560
gattacgcgc?agaaaaaaag?gatctcaaga?agatcctttg?atcttttcta?cggggtctga 4620
cgctcagtgg?aacgaaaact?cacgttaagg?gattttggtc?atgagattat?caaaaaggat 4680
cttcacctag?atccttttaa?attaaaaatg?aagttttaaa?tcaatctaaa?gtatatatga 4740
gtaaacttgg?tctgacagtt?accaatgctt?aatcagtgag?gcacctatct?cagcgatctg 4800
tctatttcgt?tcatccatag?ttgcctgact?ccccgtcgtg?tagataacta?cgatacggga 4860
gggcttacca?tctggcccca?gtgctgcaat?gataccgcga?gacccacgct?caccggctcc 4920
agatttatca?gcaataaacc?agccagccgg?aagggccgag?cgcagaagtg?gtcctgcaac 4980
tttatccgcc?tccatccagt?ctattaattg?ttgccgggaa?gctagagtaa?gtagttcgcc 5040
agttaatagt?ttgcgcaacg?ttgttgccat?tgctacaggc?atcgtggtgt?cacgctcgtc 5100
gtttggtatg?gcttcattca?gctccggttc?ccaacgatca?aggcgagtta?catgatcccc 5160
catgttgtgc?aaaaaagcgg?ttagctcctt?cggtcctccg?atcgttgtca?gaagtaagtt 5220
ggccgcagtg?ttatcactca?tggttatggc?agcactgcat?aattctctta?ctgtcatgcc 5280
atccgtaaga?tgcttttctg?tgactggtga?gtactcaacc?aagtcattct?gagaatagtg 5340
tatgcggcga?ccgagttgct?cttgcccggc?gtcaatacgg?gataataccg?cgccacatag 5400
cagaacttta?aaagtgctca?tcattggaaa?acgttcttcg?gggcgaaaac?tctcaaggat 5460
cttaccgctg?ttgagatcca?gttcgatgta?acccactcgt?gcacccaact?gatcttcagc 5520
atcttttact?ttcaccagcg?tttctgggtg?agcaaaaaca?ggaaggcaaa?atgccgcaaa 5580
aaagggaata?agggcgacac?ggaaatgttg?aatactcata?ctcttccttt?ttcaatatta 5640
ttgaagcatt?tatcagggtt?attgtctcat?gagcggatac?atatttgaat?gtatttagaa 5700
aaataaacaa?ataggggttc?cgcgcacatt?tccccgaaaa?gtgccacctg?acgtctaaga 5760
aaccattatt?atcatgacat?taacctataa?aaataggcgt?atcacgaggc?cctttcgtct 5820
tcac 5824
<210>4
<211>7797
<212>DNA
<213〉plasmid pLY-10
<400>4
atccggatat?agttcctcct?ttcagcaaaa?aacccctcaa?gacccgttta?gaggccccaa 60
ggggttatgc?tagttattgc?tcagcggtgg?cagcagccaa?ctcagcttcc?tttcgggctt 120
tgttagcagc?cggatctcag?tggtggtggt?ggtggtgctc?gagtgcggcc?gcaagctttt 180
aactcaaggc?ctcgaattgt?tgccaacaca?gatacaaagc?acggggtaca?tgaaaacatc 240
ccttccattt?accgcctttg?agatttaaca?gcacttcccc?acggcgattt?aagtagccaa 300
accactcacc?atattctggg?tcagcaaaat?gctgccaaga?ataatcgtgc?attttttgat 360
accattccca?acagacttca?cgacctgtca?aacgataacc?catcgccaaa?gccaccaaag 420
attctaaatg?cacccaccac?aatttttgat?cccattccaa?ttgttgtggg?ggatgacctg 480
ctgcatccat?aaagtaatac?aagccgccat?actctttatc?ccaggcgaaa?ttgaggatat 540
ttaacaccac?atcaactgct?tggttaatag?tcttgctgtc?gtttttccgt?cgggcgatgt 600
ccataataaa?ccacatcgcc?tcaataccgt?gaccagggtt?aatcagccgc?ccttcaaaac 660
aatcaatgtg?ggaaccatcg?ggggcaacat?tttcatacat?caatcctcgt?tctttgtcga 720
gaaagtcact?cataacttcc?tgaacggttg?cactcaagac?attttctaga?gtctcctggg 780
gaagcaacca?ttccatttct?aaggtcaggt?tagctaaaat?cattggcaca?gctaaggctt 840
tcatggggcg?tgtgccggga?taggttttgg?tatatttgcc?tttgggatta?tctttgcgac 900
gcaaaacatt?gttatatgct?tgcatagcca?catcttttgc?ccactcttca?ccagaggcga 960
gagcatattg?gctaaaggcc?atcgctgcaa?aacaatcaga?aaaaatattg?taaggctgta 1020
ctaatggttc?acctccacgg?gtgagggcaa?aataccagtt?tccctctgcg?tctctgccat 1080
gttgggcaag?aaatttagca?ccgttactag?caattttgag?ccagttttcc?cgtttttcta 1140
gctggttaca?cagcatggaa?aaagtccaga?cttggcggtt?ttgcagccaa?ataaatttat 1200
ctgtgtcata?caccttaccc?tggcgatcaa?gacaggtaaa?ataaccgcct?tccgtatcca 1260
gggagtggtt?ttcccaaaac?gggagtacgt?cgttgaggag?ggcatttttg?taaagttgcg 1320
ccagtgcttg?taagtttttc?cccatatgta?tatctccttc?ttaaagttaa?acaaaattat 1380
ttctagaggg?gaattgttat?ccgctcacaa?ttcccctata?gtgagtcgta?ttaatttcgc 1440
gggatcgaga?tcgatctcga?tcctctacgc?cggacgcatc?gtggccggca?tcaccggcgc 1500
cacaggtgcg?gttgctggcg?cctatatcgc?cgacatcacc?gatggggaag?atcgggctcg 1560
ccacttcggg?ctcatgagcg?cttgtttcgg?cgtgggtatg?gtggcaggcc?ccgtggccgg 1620
gggactgttg?ggcgccatct?ccttgcatgc?atccggatat?agttcctcct?ttcagcaaaa 1680
aacccctcaa?gacccgttta?gaggccccaa?ggggttatgc?tagttattgc?tcagcggtgg 1740
cagcagccaa?ctcagcttcc?tttcgggctt?tgttagcagc?cggatctcag?tggtggtggt 1800
ggtggtgctc?gagtgcggcc?gcaagctttc?acccgcgctc?ttgcatcaac?tgctgggcca 1860
gcgccttcag?ttctggcaga?tatttttcat?ctaccggtcc?aaacggtttg?cggcacagcg 1920
gcacagaaac?gacatccata?taatggagga?cagttttcag?gccgcggaat?acgcccgttt 1980
tgatcagtaa?atcaatgact?ttattgcatt?cagtttgcag?tttctgcgcg?gtctggatat 2040
cgccttcttt?cagcgcctta?acgatcccct?gatagcgcca?gcccatgatg?ttgtaggtac 2100
tgccgatacc?accatcagcg?cccgccagca?gaccagaggc?gaagatttcg?tcgtaaccgt 2160
tatagagcac?aagatcagga?tgttcacgac?ggatctgctc?catctgatag?agatcgccag 2220
aggtctgttt?cagcgcacct?acgccaggca?atgtaacaag?tgtgttgatc?tgatccaggg 2280
tcagttttac?cccactcagg?gctggaatgt?tgtacaccac?catcggcaaa?ccatccgccg 2340
aatcaataat?tgcccgatag?tgatcgcagt?gttcttcaaa?gctgaaagga?tagtagaacg 2400
gcgtgacggc?ggagacggca?tcgaagccat?aacgtttagc?cgatgccgca?agttgttggc 2460
tttcggcggt?gctgacgcaa?ccgacgtggg?cgatgagttt?aatcttacct?ttcgcctctt 2520
cggcgacgat?ttccagtacc?tgttcacgct?cggaaaggct?ttgtacaaag?gcctcgccgg 2580
tcgaaccacc?cacgtataaa?ccgtcgatgc?cctgctgaat?attgaactga?accaggcgac 2640
gcagactcgc?tttatccagt?gcttgttgtt?ggtcaaaagg?agtcaggagt?gcagccatta 2700
cgccacgtaa?attcgttgcc?atatgtatat?ctccttctta?aagttaaaca?aaattatttc 2760
tagaggggaa?ttgttatccg?ctcacaattc?ccctatagtg?agtcgtatta?atttcgcggg 2820
atcgagatcg?atctcgatcc?tctacgccgg?acgcatcgtg?gccggcatca?ccggcgccac 2880
aggtgcggtt?gctggcgcct?atatcgccga?catcaccgat?ggggaagatc?gggctcgcca 2940
cttcgggctc?atgagcgctt?gtttcggcgt?gggtatggtg?gcaggccccg?tggccggggg 3000
actgttgggc?gccatctcct?tgcatgcacc?attccttgcg?gcggcggtgc?tcaacggcct 3060
caacctacta?ctgggctgct?tcctaatgca?ggagtcgcat?aagggagagc?gtcgagatcc 3120
cggacaccat?cgaatggcgc?aaaacctttc?gcggtatggc?atgatagcgc?ccggaagaga 3180
gtcaattcag?ggtggtgaat?gtgaaaccag?taacgttata?cgatgtcgca?gagtatgccg 3240
gtgtctctta?tcagaccgtt?tcccgcgtgg?tgaaccaggc?cagccacgtt?tctgcgaaaa 3300
cgcgggaaaa?agtggaagcg?gcgatggcgg?agctgaatta?cattcccaac?cgcgtggcac 3360
aacaactggc?gggcaaacag?tcgttgctga?ttggcgttgc?cacctccagt?ctggccctgc 3420
acgcgccgtc?gcaaattgtc?gcggcgatta?aatctcgcgc?cgatcaactg?ggtgccagcg 3480
tggtggtgtc?gatggtagaa?cgaagcggcg?tcgaagcctg?taaagcggcg?gtgcacaatc 3540
ttctcgcgca?acgcgtcagt?gggctgatca?ttaactatcc?gctggatgac?caggatgcca 3600
ttgctgtgga?agctgcctgc?actaatgttc?cggcgttatt?tcttgatgtc?tctgaccaga 3660
cacccatcaa?cagtattatt?ttctcccatg?aagacggtac?gcgactgggc?gtggagcatc 3720
tggtcgcatt?gggtcaccag?caaatcgcgc?tgttagcggg?cccattaagt?tctgtctcgg 3780
cgcgtctgcg?tctggctggc?tggcataaat?atctcactcg?caatcaaatt?cagccgatag 3840
cggaacggga?aggcgactgg?agtgccatgt?ccggttttca?acaaaccatg?caaatgctga 3900
atgagggcat?cgttcccact?gcgatgctgg?ttgccaacga?tcagatggcg?ctgggcgcaa 3960
tgcgcgccat?taccgagtcc?gggctgcgcg?ttggtgcgga?catctcggta?gtgggatacg 4020
acgataccga?agacagctca?tgttatatcc?cgccgttaac?caccatcaaa?caggattttc 4080
gcctgctggg?gcaaaccagc?gtggaccgct?tgctgcaact?ctctcagggc?caggcggtga 4140
agggcaatca?gctgttgccc?gtctcactgg?tgaaaagaaa?aaccaccctg?gcgcccaata 4200
cgcaaaccgc?ctctccccgc?gcgttggccg?attcattaat?gcagctggca?cgacaggttt 4260
cccgactgga?aagcgggcag?tgagcgcaac?gcaattaatg?taagttagct?cactcattag 4320
gcaccgggat?ctcgaccgat?gcccttgaga?gccttcaacc?cagtcagctc?cttccggtgg 4380
gcgcggggca?tgactatcgt?cgccgcactt?atgactgtct?tctttatcat?gcaactcgta 4440
ggacaggtgc?cggcagcgct?ctgggtcatt?ttcggcgagg?accgctttcg?ctggagcgcg 4500
acgatgatcg?gcctgtcgct?tgcggtattc?ggaatcttgc?acgccctcgc?tcaagccttc 4560
gtcactggtc?ccgccaccaa?acgtttcggc?gagaagcagg?ccattatcgc?cggcatggcg 4620
gccccacggg?tgcgcatgat?cgtgctcctg?tcgttgagga?cccggctagg?ctggcggggt 4680
tgccttactg?gttagcagaa?tgaatcaccg?atacgcgagc?gaacgtgaag?cgactgctgc 4740
tgcaaaacgt?ctgcgacctg?agcaacaaca?tgaatggtct?tcggtttccg?tgtttcgtaa 4800
agtctggaaa?cgcggaagtc?agcgccctgc?accattatgt?tccggatctg?catcgcagga 4860
tgctgctggc?taccctgtgg?aacacctaca?tctgtattaa?cgaagcgctg?gcattgaccc 4920
tgagtgattt?ttctctggtc?ccgccgcatc?cataccgcca?gttgtttacc?ctcacaacgt 4980
tccagtaacc?gggcatgttc?atcatcagta?acccgtatcg?tgagcatcct?ctctcgtttc 5040
atcggtatca?ttacccccat?gaacagaaat?cccccttaca?cggaggcatc?agtgaccaaa 5100
caggaaaaaa?ccgcccttaa?catggcccgc?tttatcagaa?gccagacatt?aacgcttctg 5160
gagaaactca?acgagctgga?cgcggatgaa?caggcagaca?tctgtgaatc?gcttcacgac 5220
cacgctgatg?agctttaccg?cagctgcctc?gcgcgtttcg?gtgatgacgg?tgaaaacctc 5280
tgacacatgc?agctcccgga?gacggtcaca?gcttgtctgt?aagcggatgc?cgggagcaga 5340
caagcccgtc?agggcgcgtc?agcgggtgtt?ggcgggtgtc?ggggcgcagc?catgacccag 5400
tcacgtagcg?atagcggagt?gtatactggc?ttaactatgc?ggcatcagag?cagattgtac 5460
tgagagtgca?ccatatatgc?ggtgtgaaat?accgcacaga?tgcgtaagga?gaaaataccg 5520
catcaggcgc?tcttccgctt?cctcgctcac?tgactcgctg?cgctcggtcg?ttcggctgcg 5580
gcgagcggta?tcagctcact?caaaggcggt?aatacggtta?tccacagaat?caggggataa 5640
cgcaggaaag?aacatgtgag?caaaaggcca?gcaaaaggcc?aggaaccgta?aaaaggccgc 5700
gttgctggcg?tttttccata?ggctccgccc?ccctgacgag?catcacaaaa?atcgacgctc 5760
aagtcagagg?tggcgaaacc?cgacaggact?ataaagatac?caggcgtttc?cccctggaag 5820
ctccctcgtg?cgctctcctg?ttccgaccct?gccgcttacc?ggatacctgt?ccgcctttct 5880
cccttcggga?agcgtggcgc?tttctcatag?ctcacgctgt?aggtatctca?gttcggtgta 5940
ggtcgttcgc?tccaagctgg?gctgtgtgca?cgaacccccc?gttcagcccg?accgctgcgc 6000
cttatccggt?aactatcgtc?ttgagtccaa?cccggtaaga?cacgacttat?cgccactggc 6060
agcagccact?ggtaacagga?ttagcagagc?gaggtatgta?ggcggtgcta?cagagttctt 6120
gaagtggtgg?cctaactacg?gctacactag?aaggacagta?tttggtatct?gcgctctgct 6180
gaagccagtt?accttcggaa?aaagagttgg?tagctcttga?tccggcaaac?aaaccaccgc 6240
tggtagcggt?ggtttttttg?tttgcaagca?gcagattacg?cgcagaaaaa?aaggatctca 6300
agaagatcct?ttgatctttt?ctacggggtc?tgacgctcag?tggaacgaaa?actcacgtta 6360
agggattttg?gtcatgaaca?ataaaactgt?ctgcttacat?aaacagtaat?acaaggggtg 6420
ttatgagcca?tattcaacgg?gaaacgtctt?gctctaggcc?gcgattaaat?tccaacatgg 6480
atgctgattt?atatgggtat?aaatgggctc?gcgataatgt?cgggcaatca?ggtgcgacaa 6540
tctatcgatt?gtatgggaag?cccgatgcgc?cagagttgtt?tctgaaacat?ggcaaaggta 6600
gcgttgccaa?tgatgttaca?gatgagatgg?tcagactaaa?ctggctgacg?gaatttatgc 6660
ctcttccgac?catcaagcat?tttatccgta?ctcctgatga?tgcatggtta?ctcaccactg 6720
cgatccccgg?gaaaacagca?ttccaggtat?tagaagaata?tcctgattca?ggtgaaaata 6780
ttgttgatgc?gctggcagtg?ttcctgcgcc?ggttgcattc?gattcctgtt?tgtaattgtc 6840
cttttaacag?cgatcgcgta?tttcgtctcg?ctcaggcgca?atcacgaatg?aataacggtt 6900
tggttgatgc?gagtgatttt?gatgacgagc?gtaatggctg?gcctgttgaa?caagtctgga 6960
aagaaatgca?taaacttttg?ccattctcac?cggattcagt?cgtcactcat?ggtgatttct 7020
cacttgataa?ccttattttt?gacgagggga?aattaatagg?ttgtattgat?gttggacgag 7080
tcggaatcgc?agaccgatac?caggatcttg?ccatcctatg?gaactgcctc?ggtgagtttt 7140
ctccttcatt?acagaaacgg?ctttttcaaa?aatatggtat?tgataatcct?gatatgaata 7200
aattgcagtt?tcatttgatg?ctcgatgagt?ttttctaaga?attaattcat?gagcggatac 7260
atatttgaat?gtatttagaa?aaataaacaa?ataggggttc?cgcgcacatt?tccccgaaaa 7320
gtgccacctg?aaattgtaaa?cgttaatatt?ttgttaaaat?tcgcgttaaa?tttttgttaa 7380
atcagctcat?tttttaacca?ataggccgaa?atcggcaaaa?tcccttataa?atcaaaagaa 7440
tagaccgaga?tagggttgag?tgttgttcca?gtttggaaca?agagtccact?attaaagaac 7500
gtggactcca?acgtcaaagg?gcgaaaaacc?gtctatcagg?gcgatggccc?actacgtgaa 7560
ccatcaccct?aatcaagttt?tttggggtcg?aggtgccgta?aagcactaaa?tcggaaccct 7620
aaagggagcc?cccgatttag?agcttgacgg?ggaaagccgg?cgaacgtggc?gagaaaggaa 7680
gggaagaaag?cgaaaggagc?gggcgctagg?gcgctggcaa?gtgtagcggt?cacgctgcgc 7740
gtaaccacca?cacccgccgc?gcttaatgcg?ccgctacagg?gcgcgtccca?ttcgcca 7797

Claims (16)

1, a kind of double gene coexpression plasmid is characterized in that, described plasmid comprises N-n acetylneuraminic acid n lyase genes, N-acetyl-D-glucosamine 2-isomerase gene and a kind of suitable expression vector.
2, plasmid as claimed in claim 1 is characterized in that, described expression vector is selected from pET30a, pET29a or pQE30.
3, plasmid as claimed in claim 1 is characterized in that, described its sequence of N-n acetylneuraminic acid n lyase genes is shown in the 1829-2722 of the 151-1044 of 1854-2747, the SEQ ID NO:3 of SEQ ID NO:1 or SEQ ID NO:4.
4, plasmid as claimed in claim 1 is characterized in that, described N-acetyl-its sequence of D-glucosamine 2-isomerase gene is shown in the 182-1345 of the 1383-2546 of 179-1342, the SEQ ID NO:3 of SEQ ID NO:1 or SEQ ID NO:4.
As each described plasmid among the claim 1-4, it is characterized in that 5, described plasmid sequence is shown in SEQ ID NO:1, SEQ ID NO:3 or SEQ ID NO:4.
6, as the construction process of plasmid as described in each among the claim 1-5, it is characterized in that, said method comprising the steps of:
A) design and synthesize suitable primer, carry out pcr amplification and be connected with suitable carrier, preparation comprises the subclone plasmid of N-n acetylneuraminic acid n lyase genes;
B) enzyme is cut the plasmid that comprises N-acetyl-D-glucosamine 2-isomerase gene, obtains N-acetyl-D-glucosamine 2-isomerase gene endonuclease bamhi;
C) use with the B step in same enzyme, enzyme is cut the subclone plasmid that the A step obtains, and obtains the plasmid enzyme restriction fragment;
D) endonuclease bamhi of Connection Step B and C acquisition.
7, method as claimed in claim 6 is characterized in that, described carrier is selected from pET30a, pET29a or pQE30.
8, method as claimed in claim 6 is characterized in that, described its sequence of N-n acetylneuraminic acid n lyase genes is shown in the 1829-2722 of the 151-1044 of 1854-2747, the SEQ ID NO:3 of SEQ ID NO:1 or SEQ ID NO:4.
9, method as claimed in claim 6 is characterized in that, described N-acetyl-its sequence of D-glucosamine 2-isomerase gene is shown in the 182-1345 of the 1383-2546 of 179-1342, the SEQ ID NO:3 of SEQ ID NO:1 or SEQ ID NO:4.
10, method as claimed in claim 6 is characterized in that, described plasmid sequence is shown in SEQ ID NO:1 or SEQID NO:3 or SEQ ID NO:4.
11, transform the engineering bacteria that obtains as each described plasmid among the claim 1-5.
12, engineering bacteria as claimed in claim 11 is characterized in that, described engineering bacterial strain is intestinal bacteria.
13, engineering bacteria as claimed in claim 11 is characterized in that, described engineering bacteria is expressed N-n acetylneuraminic acid n lyase and N-acetyl-D-glucosamine 2-isomerase after cultivating.
14, as the preparation method of the described engineering bacteria of claim 11-13, it is characterized in that, may further comprise the steps:
A, with claim 1-6 described double gene coexpression plasmid transformed competence colibacillus cell and on selective medium, cultivate;
B, select positive transformant.
15, method as claimed in claim 14 is characterized in that, comprises that also the positive transformant that will obtain carries out the step of amplification cultivation.
16, a kind of method of producing Neu5Ac is characterized in that, and is centrifugal behind the bacterial cell disruption with the described engineering bacterium fermentation cultivation of claim 11-13 acquisition, and centrifugal supernatant is added the GlcNAc reaction solution, and catalysis generates Neu5Ac.
CN200810034359A 2008-03-07 2008-03-07 Dual-gene co-expression plasmid, engineering bacteria transformed therefrom and construction method thereof Pending CN101525627A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200810034359A CN101525627A (en) 2008-03-07 2008-03-07 Dual-gene co-expression plasmid, engineering bacteria transformed therefrom and construction method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200810034359A CN101525627A (en) 2008-03-07 2008-03-07 Dual-gene co-expression plasmid, engineering bacteria transformed therefrom and construction method thereof

Publications (1)

Publication Number Publication Date
CN101525627A true CN101525627A (en) 2009-09-09

Family

ID=41093698

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200810034359A Pending CN101525627A (en) 2008-03-07 2008-03-07 Dual-gene co-expression plasmid, engineering bacteria transformed therefrom and construction method thereof

Country Status (1)

Country Link
CN (1) CN101525627A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101979644A (en) * 2010-09-10 2011-02-23 扬州博生源生物科技有限公司 Method for preparing N-acetylneuraminic acid by one-step catalysis of fusion protein
CN102703371A (en) * 2012-07-03 2012-10-03 天津科技大学 Escherichia coli engineering bacteria for producing L-serine with high yield and fermentation method for engineering bacteria
CN103060358A (en) * 2011-10-20 2013-04-24 中国科学院微生物研究所 Genetically engineered bacteria for producing N-acetylneuraminic acid as well as construction method and application thereof
CN115925980A (en) * 2022-08-17 2023-04-07 深圳大学 Fusion protease, fusion expression vector, engineering bacterium and production method of N-acetylneuraminic acid

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101979644A (en) * 2010-09-10 2011-02-23 扬州博生源生物科技有限公司 Method for preparing N-acetylneuraminic acid by one-step catalysis of fusion protein
CN103060358A (en) * 2011-10-20 2013-04-24 中国科学院微生物研究所 Genetically engineered bacteria for producing N-acetylneuraminic acid as well as construction method and application thereof
CN102703371A (en) * 2012-07-03 2012-10-03 天津科技大学 Escherichia coli engineering bacteria for producing L-serine with high yield and fermentation method for engineering bacteria
CN115925980A (en) * 2022-08-17 2023-04-07 深圳大学 Fusion protease, fusion expression vector, engineering bacterium and production method of N-acetylneuraminic acid

Similar Documents

Publication Publication Date Title
CN106459957B (en) Method for modifying genome sequence for specifically converting nucleic acid base of target DNA sequence, and molecular complex used therefor
CN107686848A (en) The stable of transposons collaboration CRISPR/Cas9 systems knocks out single plasmid vector and its application
CN109735480B (en) Recombinant bacillus subtilis for synthesizing lactyl-N-neotetraose and construction method and application thereof
CN113563476A (en) RNA-guided targeting of genetic and epigenetic regulatory proteins to specific genomic loci
CN110079551B (en) Circular RNA expression vector and construction method and application thereof
KR101535555B1 (en) Recombinant foot and mouth disease viruses using the vaccine strain, O manisa strain for protection of ME-SA topotype of O serotyp
CN109825465B (en) Recombinant bacillus subtilis for synthesizing lactyl-N-neotetraose based on balanced UDP-sugar supply and construction method and application thereof
US20020045185A1 (en) Secreted neural adhesion proteins
CN101525627A (en) Dual-gene co-expression plasmid, engineering bacteria transformed therefrom and construction method thereof
CN109810958B (en) Saffron-derived CCD2 mutant, coding sequence and application thereof, and recombinant yeast strain for producing crocetin
KR102277898B1 (en) Yeast having a improved product productivity and method of producint the product
CN111607614A (en) Construction method and application of CD45-DTR transgenic mouse for regulating and eliminating immune cells by diphtheria toxin
KR20160012561A (en) Genetically engineered and acid resistant yeast cell with enhanced ERG5 activity and method for producing lactate using the same
CN100591771C (en) Hypoxia response elements gene treating plasmid and its constructing method
KR102349954B1 (en) Yeast having a improved product productivity and method of producint the product
CN107400679A (en) Plasmid vector and its application for being overexpressed stability series are established based on transposase
KR101578441B1 (en) Foot-and-mouth disease virus expressing P1-protective antigen of O-PanAsia-2 strain and the manufacturing methods
CN113880957A (en) Streptolysin O fusion protein
KR101546810B1 (en) Foot-and-mouth disease recombinant virus expressing P1-protective antigen of O serotype-SEA topotype, and the viral vaccine comprising the same
CN114773441B (en) Application of Hot1p as positive control factor in improving protein expression in host cell
KR102009268B1 (en) Recombinant foot-and-mouth disease virus expressing protective antigen of type C3 Resende
CN114657197B (en) Application of Gsm1p as positive control factor in improving protein expression in host cell
KR101488110B1 (en) Mutant Neq HS DNA polymerases from Nanoarchaeum equitans and its application to hot-start PCR
CN113354718A (en) Piranin precursor, expression cassette and preparation method thereof
CN101517076B (en) Genetic remodeling in bifidobacterium

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20090909